Originally published by our sister publication Pain Medicine News
By Bob Kronemyer

An observational study published in JAMA Health Forum found that the out-of-pocket cost of naloxone for uninsured patients skyrocketed by over 500% from 2014 to 2018 (2022;3[8]:e222663).
“There have been increasing efforts to expand access to naloxone, with a variety of different laws passed by states across the nation,” said lead author Evan Peet, PhD, an economist at the RAND Corporation